Cianna Medical’s radar technology was recently featured in MED DEVICE ONLINE. The article, Radar Technology Is Changing the Standard of Care for Breast Tumor Localization, is authored by Charles Cox, MD, the McCann Foundation Endowed Professor of Breast Surgery at the University of South Florida.
The SCOUT Radar Localization system was designed for use by surgeons and radiologists to precisely locate and guide the removal of a tumor during a lumpectomy or surgical biopsy procedure. Using SCOUT, surgeons can precisely target the affected tissue using its 360˚ detection capability to pinpoint its location within ±1mm, which can mean more successful surgeries, optimized breast conservation strategies and enhanced outcomes for women.
The SCOUT system has the first and only non-radioactive implant used in wire-free localization that can be implanted with no restrictions on the length of time the reflector can remain in the breast. This enables additional efficiencies by allowing localization procedures to be performed prior to neoadjuvant therapy or at the time of biopsy, which could eliminate the localization procedure performed closer to the time of excision surgery. In addition, because the SCOUT reflector will not interfere with MRI studies, patients are not restricted in the types of imaging modalities they may need.
In his article Dr. Cox discussed the ideal breast tumor localization that encompasses; detection, localization and identification and how radar plays a key role in each. He cites the following:
Radar technology achieves the three critical elements of a breast tumor localization technology. It has a detection range of 60 mm and enables unparalleled localization precision through real-time distance measurement. Radar achieves accuracy of ±1 mm in 360 degrees around the target. Additionally, the reflectors used in radar-based systems have minimal artifact on magnetic resonance imaging scans and minimize interference with high-quality imaging technologies.
In addition to providing excellent surgical outcomes, radar-based localization offers several additional clinical benefits. The reflector is easily imaged, allowing for accurate placement and planning. The ability to place the reflector at the tumor site at any time during the continuum of care is driving improvements in efficiency by uncoupling radiology and surgery schedules, and giving these departments greater flexibility to meet patient needs while reducing or eliminating surgical delays.
Dr. Cox states that these benefits, taken together, position radar-based technology to become the wire-free standard of care technique for breast lesion localization and most importantly, allow more women to receive optimized breast cancer treatment.